Search results for "Ulcerative Colitis"

showing 10 items of 237 documents

P611 Outcome in ulcerative colitis after switch from subcutaneous anti-TNF to intravenous anti-TNF: A multicentre study

2018

medicine.medical_specialtybusiness.industryInternal medicineGastroenterologyMedicineTumor necrosis factor alphaGeneral Medicinebusinessmedicine.diseaseUlcerative colitisGastroenterologyJournal of Crohn's and Colitis
researchProduct

Chromoendoscopy: An Evolving Standard in Surveillance for Ulcerative Colitis

2004

medicine.medical_specialtybusiness.industryInternal medicineGastroenterologymedicineImmunology and Allergybusinessmedicine.diseaseGastroenterologyUlcerative colitisChromoendoscopyInflammatory Bowel Diseases
researchProduct

Ulcerative colitis - How can we improve surveillance colonoscopy?

2003

medicine.medical_specialtybusiness.industryInternal medicinemedicineGeneral Medicinemedicine.diseasebusinessUlcerative colitisGastroenterologyDMW - Deutsche Medizinische Wochenschrift
researchProduct

Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives

2017

This concise commentary deals with the manuscript, in the issue 10, volume 32 of Digestive Diseases and Sciences 2017, by Aggarwal et al. which provides data supporting the contribution of GABA and GABAergic signalling to the pathogenesis of ulcerative colitis (UC) in humans

medicine.medical_specialtybusiness.industryPhysiologyGastroenterologyHepatologymedicine.diseaseUlcerative colitisGastroenterologySettore BIO/09 - FisiologiaTransplant surgeryInternal medicinemedicineGABAergicHumansColitis Ulcerativebusiness
researchProduct

Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: Clinical Response without Endoscopic Response

2006

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentGastroenterology.medicine.diseaseGastroenterologyUlcerative colitisSteroidInternal medicinemedicineImmunology and AllergyIn patientDependantbusinessInflammatory Bowel Diseases
researchProduct

Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight

2004

Chromoendoscopy in ulcerative colitis may offer the possibility of detecting dysplastic or neoplastic changes at a curable stage, and thus expand the indication for chromoendoscopy from screening to surveillance colonoscopy Colonoscopy is the gold standard for colorectal cancer screening.1–3 Detection and complete removal of adenomas disrupt the adenoma-carcinoma sequence and thus prevent the development of colorectal cancer. However, endoscopists still fear that they may have overlooked relevant lesions despite the availability of modern videoendoscopes. This problem is underlined by a relatively high rate of adenomas missed by conventional endoscopy (up to 27%), as determined by back to b…

medicine.medical_specialtymedicine.diagnostic_testAdenomabusiness.industryColorectal cancerGastroenterologyColonoscopymedicine.diseaseGastroenterologyUlcerative colitisdigestive system diseasesChromoendoscopyFlat AdenomaIntestinal mucosaInternal medicineCommentaryMedicinebusinessMass screening
researchProduct

Colonoscopy, Tumors, and Inflammatory Bowel Disease - New Diagnostic Methods

2006

Accurate detection of premalignant lesions and early cancers in the colon is essential for curative endoscopic or surgical therapy, since the prognosis for the affected patients is closely related to the size and stage of the neoplastic lesion. Total colonoscopy is the accepted gold standard for screening and surveillance of colorectal cancer. This review summarizes recently published diagnostic developments and key findings in the areas of colonoscopy, colonic tumors, and inflammatory bowel diseases. Relevant findings have been reported for chromo-endoscopy in the diagnosis of colitis-associated neoplasia, as well as flat and depressed adenomas. Real-time Doppler capabilities have now been…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryColorectal cancerGastroenterologyColonoscopyColonoscopyEquipment DesignGold standard (test)Colitismedicine.diseaseInflammatory bowel diseaseGastroenterologyUlcerative colitisEndoscopyEndoscopes GastrointestinalInternal medicineColonic NeoplasmsmedicineEndomicroscopyHumansColitis UlcerativeStage (cooking)businessTomography Optical CoherenceEndoscopy
researchProduct

P275 Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO score (the Paddington International Virtual Chromoe…

2017

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrySurrogate endpointGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisEndoscopyChromoendoscopymedicineRadiologybusinessReliability (statistics)Journal of Crohn's and Colitis
researchProduct

Infliximab and ulcerative colitis

2006

Expert Opin Biol Ther. 2006 Apr;6(4):401-8. Infliximab and ulcerative colitis. Cottone M, Mocciaro F, Modesto I. Università di Palermo, Istituto di Medicina Generale e Pneumologia, Via Trabucco 180, Palermo, Italy. dickens@tin.it Tumour necrosis factor (TNF)-alpha is an inflammatory cytokine that plays a main role in the inflammatory process underlying inflammatory bowel disease (IBD). Despite the fact that the cytokine profiles associated with ulcerative colitis (UC) and Crohn's disease (CD) are classically considered different (a Th2 pattern in UC and a Th1 pattern in CD), there are several evidences in vitro and in vivo that TNF-alpha has an important role in UC. For this reason, inflixi…

medicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryInflammatory bowel diseaseGastroenterologyGastrointestinal AgentsInternal medicineDrug Discoverymedicineinfliximab. ulcerative colitisHumansColitisPharmacologyGastrointestinal agentbusiness.industryAntibodies MonoclonalPouchitismedicine.diseaseUlcerative colitisInfliximabInfliximabCytokineImmunologyColitis UlcerativeTumor necrosis factor alphabusinessmedicine.drugExpert Opinion on Biological Therapy
researchProduct

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guideline…

2010

Biological therapies are an important step in the management of Inflammatory Bowel Diseases. In consideration of high cost and safety issues there is the need to have clear recommendations for their use. Despite the American Gastroenterological Association and the European Crohn's and Colitis Organisation have published exhaustive Inflammatory Bowel Disease guidelines, national guidelines may be necessary as cultural values, economical and legal issues may differ between countries. For these reasons the Italian Society of Gastroenterology and the Italian Group for the study of Inflammatory Bowel Disease have decided to elaborate the Italian guidelines on the use of biologics in Inflammatory…

methods Tumor Necrosis Factor-alphaAnti-Inflammatory AgentsUlcerativeDiseaseGUIDELINESHumanized Antibodieetiology Pregnancy Pregnancy ComplicationGastroenterologyInflammatory bowel diseaseetiology Opportunistic InfectionCrohn DiseasePregnancyNeoplasmsMonoclonaldrug therapy Remission Inductionantagonists /&/ inhibitorsSettore MED/12 - GastroenterologiaRemission InductionGastroenterologyAntibodies MonoclonalUlcerative colitisAnti-Inflammatory AgentItalyadverse effects/therapeutic use Intestinal FistulaTumor necrosis factor alphaFemaleImmunosuppressive Agentsmedicine.drugbiological drugsmedicine.medical_specialtyIBDOpportunistic InfectionsAntibodies Monoclonal HumanizedAutoimmune Diseasesadverse effects/therapeutic use Autoimmune DiseaseInternal medicinemedicineAdalimumabIntestinal FistulaHumansColitisdiagnosis/drug therapy/surgery Italy Neoplasmadverse effects/therapeutic use AntibodieHepatologydrug therapy Female Humans Immunosuppressive Agentbusiness.industryTumor Necrosis Factor-alphaAdalimumabCancermedicine.diseaseInfliximabInfliximabdigestive system diseasesdrug therapy Crohn Diseaseetiology ColitiPregnancy ComplicationsColitis Ulcerativebusiness
researchProduct